Free U.S. shipping $175+

Ipamorelin — Novaryn Research
Hover to zoom
Growth Hormone ResearchSynthetic pentapeptide (selective ghrelin-receptor agonist)

Ipamorelin

$39.99
5 mg· 2 strengths available

Ipamorelin is a synthetic pentapeptide that acts as an agonist at the growth hormone secretagogue receptor (GHS-R1a), the same receptor engaged by the endogenous peptide ghrelin.

It is widely used in laboratory research because published characterization describes it as more selective than earlier secretagogue peptides, which makes it useful for isolating GHS-R1a-mediated signaling from other endocrine effects in preclinical models.

Research areas
Ghrelin receptor activityReceptor selectivity studiesSomatotroph pathway researchPreclinical research
Form: Lyophilized (freeze-dried)
Compound class
Synthetic pentapeptide (selective ghrelin-receptor agonist)
Research category
Growth Hormone Research
SKU
NVR-IPAMORELIN-5MG
Alternate name
Ipa
CAS
170851-70-4
Appearance
White lyophilized powder
Storage
Store lyophilized at −20 °C. Protect from light and moisture.
Research use only
Select strength
Cost per mg shown for each option
1
$39.99per 5 mg$8.00/mg

For research use only — not for human or animal consumption.

Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.

Research Grade
Batch Documentation
Research Use Only
U.S.-Based Fulfillment
What you should know

More detail on Ipamorelin.

Analytical values reflect per-lot documentation and appear once a batch is released.

Compound
GHS-R1a is a G-protein-coupled receptor that signals largely through the Gq/phospholipase-C pathway, producing measurable calcium mobilization in receptor assays. Ipamorelin's short, defined sequence and reported selectivity profile make it a common reference agonist in that setting. Investigators use it to compare secretagogue potency, to examine receptor desensitization over repeated stimulation, and as a positive control when characterizing novel GHS-R1a ligands. Its use here is limited to in vitro and preclinical laboratory research.
Peptide class
Synthetic pentapeptide (selective ghrelin-receptor agonist)
Mechanism (research context)
Ipamorelin engages GHSR-1a with reported selectivity relative to earlier GHRP-family peptides, which is why it is commonly used as a receptor-pharmacology reference compound.
Why it is studied
Its selectivity profile makes it a widely cited comparison peptide in ghrelin-receptor and secretagogue pharmacology.
Current areas of research
Ghrelin receptor activityReceptor selectivity studiesSomatotroph pathway researchPreclinical research

Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.

Scientific background

Ipamorelin was described in the late 1990s as one of the first selective growth hormone secretagogues, distinguishing it from broader-acting members of the GHRP series.

It is now a standard reference peptide in ghrelin-receptor research and is commonly paired with GHRH analogs such as CJC-1295 in co-treatment protocols.

Related

Related research materials

View all →
Ipamorelin
5 mg · $39.99
Notify me when available